[Fractionated opiate withdrawal with tiapride and naloxone, a new treatment approach].
To date, no satisfying solution has been found to the problem of how to avoid the distressing withdrawal symptoms accompanying opiate detoxification. By administering staggered doses of naloxone to the patient while under tiapride (Delpral-R), the various discomforts were satisfactorily reduced and the detoxification syndrome could be limited to 50 hours. This study covers 15 patients who had an average addiction history of more than 7 1/e years, and who underwent inpatient rapid opiate withdrawal treatment lasting an average of five days.
Presslich
O
O
Psychiatrische Universitätsklinik Wien.
Loimer
N
N
Aschauer
G
G
Fodor
G
G
Pfersmann
D
D
Müller
K
K
Pakesch
G
G
Lieber
A
A
D000328:Adult; D001549:Benzamides / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006556:Heroin Dependence / Q000534:rehabilitation*; D006801:Humans; D007262:Infusions, Intravenous; D007273:Injections, Intramuscular; D008297:Male; D009021:Morphine Dependence / Q000534:rehabilitation*; D009270:Naloxone / Q000627:therapeutic use*; D013375:Substance Withdrawal Syndrome / Q000534:rehabilitation*; D013976:Tiapamil Hydrochloride / Q000627:therapeutic use*
D001549:Benzamides; D009270:Naloxone; D013976:Tiapamil Hydrochloride
Fraktionierter Opiatentzug mit Tiaprid und Naloxon, ein neuer Therapieansatz.